Serum reverse triiodothyronine in dogs with hypothyroidism, nonthyroidal illness syndrome and healthy dogs
PLOS One · 2026
DOI: 10.1371/journal.pone.0357106 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Julia Ruß und 7 weiteren Autor:innen. Beteiligte Einrichtung: Royal Canin GmbH & Co. KG, Köln, Germany. Hauptthemen laut MEDLINE: Hypothyroidism, Dog Diseases, Triiodothyronine, Reverse, Euthyroid Sick Syndromes. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Gesellschaft für Veterinärdermatologie, Antech Diagnostics Germany Mars Petcare Science and Diagnostics, Viernheim, Germany.
Abstract (Originalsprache)
Background
Diagnosing canine hypothyroidism remains challenging because decreased total thyroxine (tT4) concentrations are not specific for hypothyroidism and are frequently observed in dogs with non-thyroidal illness syndrome (NTIS). Although additional thyrotropin (TSH) and free thyroxine (fT4) measurements may improve diagnostic accuracy, differentiation between hypothyroidism and NTIS remains difficult in clinical practice. In human medicine, reverse triiodothyronine (rT3), an inactive metabolite of thyroxine, has been proposed as a useful marker to distinguish hypothyroidism from NTIS. However, studies evaluating rT3 concentrations in dogs with hypothyroidism and NTIS are currently lacking.
Objective
To establish and validate a canine-specific HPLC-MS/MS assay for reverse triiodothyronine (rT3), determine a reference interval in healthy dogs, and evaluate the diagnostic utility of rT3 for differentiating canine hypothyroidism from NTIS in comparison with free thyroxine measured by equilibrium dialysis (fT4d). Materials and methods Reverse triiodothyronine (rT3) concentrations were measured by HPLC-MS/MS in healthy dogs, dogs with hypothyroidism, and dogs with NTIS. A canine-specific reference interval for rT3 was established using healthy adult dogs. Hypothyroidism was diagnosed based on compatible clinical signs, decreased total thyroxine (tT4), increased thyrotropin (TSH), and clinical improvement following levothyroxine supplementation. Dogs with moderate to severe systemic disease, decreased tT4 concentrations, and no clinical signs consistent with hypothyroidism were included in the NTIS group. The diagnostic value of rT3 in distinguishing between dogs with hypothyroidism and NTIS was investigated and compared with the diagnostic value of fT4 measured by equilibrium dialysis (fT4d) using ROC analysis.
Results
47 healthy dogs, 18 hypothyroid dogs, and 23 dogs with NTIS were included. The reference interval for rT3 was 113–439 pg/ml. Median rT3 concentrations were significantly lower in hypothyroid dogs (2.5 pg/ml; [IQR 2.5–18.5 pg/ml], range 2.5–106 pg/ml) compared with dogs with NTIS (229 pg/ml; [IQR 148.7–538.3 pg/ml], range 52.2–700 pg/ml; p < 0.0001) and healthy dogs (281 pg/ml; [IQR 220–344.5 pg/ml], range 111–817 pg/ml; p < 0.0001). The area under the ROC curve (AUC) for rT3 to differentiate hypothyroidism from NTIS was 0.981 (95% CI: 0.951–1.010), compared with 0.896 (95% CI: 0.798–0.994) for fT4d. Using cut-off values of ≤52.2 pg/ml and ≤106 pg/ml, rT3 showed sensitivities and specificities of 83.4% (95% CI: 59–96%) and 100% (95% CI: 85–100%), and 100% (95% CI: 82–100%) and 82.6% (95% CI: 61–94%), respectively. Using the lower limit of the reference interval as a cut-off, sensitivity and specificity were 77.8% (95% CI: 53–92%) and 91.3% (95% CI: 72–98%). Conclusion and clinical relevance The establishment of a reference interval for rT3 will enable future interpretation of rT3 values in dogs. rT3 represents a valuable diagnostic parameter for differentiating canine hypothyroidism from NTIS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Royal Canin GmbH & Co. KG, Köln, Germany.
- Small Animal Clinic, LMU Munich, Munich, Germany.
- Small Animal Centre Germering, Germering, Germany.
- Anicura Veterinary Clinic Haar GmbH, Haar, Germany.
- SYNLAB MVZ Labor München Zentrum GbR, Munich, Germany.
- Antech Diagnostics Germany, Mars Petcare Science and Diagnostics, Viernheim, Germany.
ORCID-Profile: Julia Ruß, Stefanie Klenner-Gastreich
Förderung
- Deutsche Gesellschaft für Veterinärdermatologie
- Antech Diagnostics Germany Mars Petcare Science and Diagnostics, Viernheim, Germany
Zitieren
APA
Ruß, J., Mueller, R. S., Glos, K., Meindl, C., Ritz, S., Müller, D. C., Klenner-Gastreich, S., & Schwens, C. (2026). Serum reverse triiodothyronine in dogs with hypothyroidism, nonthyroidal illness syndrome and healthy dogs. PLOS One. https://doi.org/10.1371/journal.pone.0357106
Vancouver
Ruß J, Mueller RS, Glos K, Meindl C, Ritz S, Müller DC, et al. Serum reverse triiodothyronine in dogs with hypothyroidism, nonthyroidal illness syndrome and healthy dogs. PLOS One. 2026. doi:10.1371/journal.pone.0357106
BibTeX
@article{Ru2026,
author = {Ruß, Julia and Mueller, Ralf S and Glos, Katharina and Meindl, Christina and Ritz, Susanne and Müller, Daniel C and Klenner-Gastreich, Stefanie and Schwens, Christina},
title = {Serum reverse triiodothyronine in dogs with hypothyroidism, nonthyroidal illness syndrome and healthy dogs},
journal = {PLOS One},
year = {2026},
doi = {10.1371/journal.pone.0357106}
}
EUVIMED